149 related articles for article (PubMed ID: 2006181)
1. Drug-induced DNA repair: X-ray structure of a DNA-ditercalinium complex.
Gao Q; Williams LD; Egli M; Rabinovich D; Chen SL; Quigley GJ; Rich A
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2422-6. PubMed ID: 2006181
[TBL] [Abstract][Full Text] [Related]
2. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
[TBL] [Abstract][Full Text] [Related]
3. DNA-ditercalinium interactions: implications for recognition of damaged DNA.
Williams LD; Gao Q
Biochemistry; 1992 May; 31(17):4315-24. PubMed ID: 1567878
[TBL] [Abstract][Full Text] [Related]
4. DNA distortion in bis-intercalated complexes.
Peek ME; Lipscomb LA; Bertrand JA; Gao Q; Roques BP; Garbay-Jaureguiberry C; Williams LD
Biochemistry; 1994 Apr; 33(13):3794-800. PubMed ID: 8142381
[TBL] [Abstract][Full Text] [Related]
5. The noncovalent complex between DNA and the bifunctional intercalator ditercalinium is a substrate for the UvrABC endonuclease of Escherichia coli.
Lambert B; Jones BK; Roques BP; Le Pecq JB; Yeung AT
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6557-61. PubMed ID: 2671994
[TBL] [Abstract][Full Text] [Related]
6. Induction of an abortive and futile DNA repair process in E. coli by the antitumor DNA bifunctional intercalator, ditercalinium: role in polA in death induction.
Lambert B; Roques BP; Le Pecq JB
Nucleic Acids Res; 1988 Feb; 16(3):1063-78. PubMed ID: 2830590
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations of the bis-intercalated complexes of ditercalinium and Flexi-Di with the hexanucleotide d(GCGCGC)2: theoretical analysis of the interaction and rationale for the sequence binding specificity.
de Pascual-Teresa B; Gallego J; Ortiz AR; Gago F
J Med Chem; 1996 Nov; 39(24):4810-24. PubMed ID: 8941395
[TBL] [Abstract][Full Text] [Related]
8. DNA sequence recognition by the antitumor drug ditercalinium.
Crow SD; Bailly C; Garbay-Jaureguiberry C; Roques B; Shaw BR; Waring MJ
Biochemistry; 2002 Jul; 41(27):8672-82. PubMed ID: 12093285
[TBL] [Abstract][Full Text] [Related]
9. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
[TBL] [Abstract][Full Text] [Related]
10. Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent.
Segal-Bendirdjian E; Coulaud D; Roques BP; Le Pecq JB
Cancer Res; 1988 Sep; 48(17):4982-92. PubMed ID: 2842043
[TBL] [Abstract][Full Text] [Related]
11. 1H- and 31P-NMR studies of ditercalinium binding to a d(GCGC)2 and d(CCTATAGG)2 minihelices: a sequence specificity study.
Delepierre M; Milhe C; Namane A; Dinh TH; Roques BP
Biopolymers; 1991 Feb; 31(3):331-53. PubMed ID: 1868161
[TBL] [Abstract][Full Text] [Related]
12. Bisintercalation of ditercalinium into a d(CpGpApTpCpG)2 minihelix: a 1H- and 31P-NMR study.
Delepierre M; Dinh TH; Roques BP
Biopolymers; 1989 Dec; 28(12):2115-42. PubMed ID: 2605314
[TBL] [Abstract][Full Text] [Related]
13. Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR.
Delbarre A; Delepierre M; Garbay C; Igolen J; Le Pecq JB; Roques BP
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2155-9. PubMed ID: 3470783
[TBL] [Abstract][Full Text] [Related]
14. Asymmetry and dynamics in bis-intercalated DNA.
Peek ME; Lipscomb LA; Haseltine J; Gao Q; Roques BP; Garbay-Jaureguiberry C; Williams LD
Bioorg Med Chem; 1995 Jun; 3(6):693-9. PubMed ID: 7582947
[TBL] [Abstract][Full Text] [Related]
15. Conformation and dynamics of drug-DNA intercalation.
Herzyk P; Neidle S; Goodfellow JM
J Biomol Struct Dyn; 1992 Aug; 10(1):97-139. PubMed ID: 1418749
[TBL] [Abstract][Full Text] [Related]
16. Effects of cationic charge on three-dimensional structures of intercalative complexes: structure of a bis-intercalated DNA complex solved by MAD phasing.
Shui X; Peek ME; Lipscomb LA; Wilkinson AP; Williams LD; Gao M; Ogata C; Roques BP; Garbay-Jaureguiberry C; Wilkinson AP; Williams LD
Curr Med Chem; 2000 Jan; 7(1):59-71. PubMed ID: 10637357
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the bis-intercalating complexes formed between either ditercalinium or a flexible analogue and d(CpGpCpG)2 or d(TpTpCpGpCpGpApA)2 minihelices: 1H- and 31P-NMR analyses.
Pothier J; Delepierre M; Barsi MC; Garbay-Jaureguiberry C; Igolen J; Le Bret M; Roques BP
Biopolymers; 1991 Oct; 31(11):1309-23. PubMed ID: 1777582
[TBL] [Abstract][Full Text] [Related]
18. Ditercalinium, a nucleic acid binder, inhibits the respiratory chain of isolated mammalian mitochondria.
Dupont J; Schwaller MA; Dodin G
Cancer Res; 1990 Dec; 50(24):7966-72. PubMed ID: 2174739
[TBL] [Abstract][Full Text] [Related]
19. Isohelicity and phasing in drug--DNA sequence recognition: crystal structure of a tris(benzimidazole)--oligonucleotide complex.
Clark GR; Gray EJ; Neidle S; Li YH; Leupin W
Biochemistry; 1996 Oct; 35(43):13745-52. PubMed ID: 8901516
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling to study DNA intercalation by anti-tumor drugs.
Neidle S; Jenkins TC
Methods Enzymol; 1991; 203():433-58. PubMed ID: 1762566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
